Literature DB >> 14981386

Pregnancies in Gaucher disease: a 5-year study.

Yonatan Elstein1, Vered Eisenberg, Sorina Granovsky-Grisaru, Ron Rabinowitz, Arnon Samueloff, Ari Zimran, Deborah Elstein.   

Abstract

OBJECTIVE: The study was undertaken to investigate the outcome of pregnancies in Gaucher disease, particularly in enzyme-treated women. STUDY
DESIGN: A retrospective study was performed of pregnant women evaluated at a referral clinic.
RESULTS: There were 43 (17 treated, 26 untreated) women with 66 pregnancies (23 treated, 43 untreated). The live birth rate was 78.3% among treated, 86.0% among untreated. One treated woman had three spontaneous abortions; 3 untreated women had one each. Four pregnancies in each group had postpartum bleeding, 7 requiring transfusions. Postpartum infections were prevalent among treated. Cesarean sections were generally for historic reasons. There was no exacerbation of Gaucher disease, except one bone crisis.
CONCLUSION: Most untreated women with milder disease enjoyed an uncomplicated course. Enzyme-treated patients (ie, with more severe disease) had more bleeding and infections post partum, but few had spontaneous abortions. Hematologic consultation is recommended. A review of world experience with pregnant patients with Gaucher disease is included.

Entities:  

Mesh:

Year:  2004        PMID: 14981386     DOI: 10.1016/j.ajog.2003.08.006

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health.

Authors:  S R Mastaglia; N P Watman; B Oliveri
Journal:  Osteoporos Int       Date:  2010-06-10       Impact factor: 4.507

2.  Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa.

Authors:  S Wendt; C Whybra; C Kampmann; E Teichmann; M Beck
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I.

Authors:  A T Anbu; J Mercer; J E Wraith
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

4.  Pregnancy issues in inherited metabolic disorders.

Authors:  Philip J Lee
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

Review 5.  Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.

Authors:  T M Cox; J M F G Aerts; N Belmatoug; M D Cappellini; S vom Dahl; J Goldblatt; G A Grabowski; C E M Hollak; P Hwu; M Maas; A M Martins; P K Mistry; G M Pastores; A Tylki-Szymanska; J Yee; N Weinreb
Journal:  J Inherit Metab Dis       Date:  2008-05-23       Impact factor: 4.982

6.  Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience.

Authors:  P Grigorescu Sido; C Drugan; V Cret; C Al-Kzouz; C Denes; C Coldea; A Zimmermann
Journal:  J Inherit Metab Dis       Date:  2007-08-20       Impact factor: 4.982

7.  Replacement Therapy for Gaucher Disease during Pregnancy: A Case Report.

Authors:  Stefano Raffaele Giannubilo; Angela Pasculli; Elisa Tidu; Andrea Ciavattini
Journal:  J Reprod Infertil       Date:  2015 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.